Tower Research Capital (TRC)’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.55M Buy
4,535
+431
+11% +$276K 0.07% 293
2025
Q4
$2.78M Buy
4,104
+1,778
+76% +$1.21M 0.07% 256
2025
Q3
$1.49M Buy
2,326
+1,187
+104% +$720K 0.04% 377
2025
Q2
$611K Sell
1,139
-1,802
-61% -$862K 0.02% 822
2025
Q1
$1.22M Sell
2,941
-3,607
-55% -$1.57M 0.04% 425
2024
Q4
$2.71M Buy
6,548
+3,729
+132% +$1.64M 0.05% 288
2024
Q3
$1.42M Sell
2,819
-9,927
-78% -$4.82M 0.04% 384
2024
Q2
$6.21M Buy
12,746
+7,259
+132% +$3.64M 0.1% 156
2024
Q1
$2.96M Sell
5,487
-7,571
-58% -$4.14M 0.07% 199
2023
Q4
$7.25M Buy
13,058
+6,598
+102% +$3.1M 0.09% 176
2023
Q3
$2.82M Buy
6,460
+4,305
+200% +$2.15M 0.09% 212
2023
Q2
$1.08M Buy
2,155
+565
+36% +$271K 0.04% 466
2023
Q1
$795K Sell
1,590
-2,350
-60% -$1.12M 0.03% 557
2022
Q4
$1.61M Sell
3,940
-16,411
-81% -$6.37M 0.07% 219
2022
Q3
$6.63M Buy
20,351
+7,491
+58% +$2.75M 0.11% 157
2022
Q2
$4.51M Sell
12,860
-11,719
-48% -$4.78M 0.1% 165
2022
Q1
$13.4M Buy
24,579
+14,262
+138% +$7.5M 0.13% 138
2021
Q4
$6.79M Buy
10,317
+5,667
+122% +$3.56M 0.12% 142
2021
Q3
$2.89M Sell
4,650
-885
-16% -$595K 0.07% 188
2021
Q2
$3.5M Sell
5,535
-5,554
-50% -$3.07M 0.09% 158
2021
Q1
$5.43M Buy
11,089
+9,265
+508% +$4.64M 0.09% 195
2020
Q4
$912K Sell
1,824
-3,078
-63% -$1.38M 0.03% 567
2020
Q3
$1.93M Buy
4,902
+1,876
+62% +$694K 0.02% 419
2020
Q2
$999K Buy
3,026
+3,022
+75,550% +$875K 0.04% 530
2020
Q1
$1K Sell
4
-50
-93% -$13K ﹤0.01% 2784
2019
Q4
$14K Sell
54
-2,398
-98% -$632K ﹤0.01% 2152
2019
Q3
$667K Buy
2,452
+2,323
+1,801% +$646K 0.05% 451
2019
Q2
$35K Sell
129
-1,513
-92% -$373K ﹤0.01% 1810
2019
Q1
$367K Sell
1,642
-218
-12% -$45K 0.02% 805
2018
Q4
$346K Buy
1,860
+1,844
+11,525% +$378K 0.02% 526
2018
Q3
$4K Sell
16
-2,605
-99% -$632K ﹤0.01% 3195
2018
Q2
$572K Buy
+2,621
New +$540K 0.03% 576
2018
Q1
Sell
-1,648
Closed -$258K 3523
2017
Q4
$258K Buy
1,648
+1,101
+201% +$173K 0.03% 482
2017
Q3
$85K Buy
+547
New +$86.5K 0.01% 1522
2017
Q1
Sell
-498
Closed -$58K 3443
2016
Q4
$58K Sell
498
-2,698
-84% -$308K 0.01% 1331
2016
Q3
$360K Buy
3,196
+479
+18% +$50.5K 0.04% 249
2016
Q2
$252K Buy
2,717
+1,224
+82% +$105K 0.02% 527
2016
Q1
$117K Buy
1,493
+1,432
+2,348% +$103K 0.02% 456
2015
Q4
$4K Sell
61
-1,389
-96% -$99.1K ﹤0.01% 3198
2015
Q3
$108K Sell
1,450
-990
-41% -$70.9K 0.01% 524
2015
Q2
$157K Buy
2,440
+2,312
+1,806% +$160K 0.01% 499
2015
Q1
$10K Sell
128
-74
-37% -$5.76K ﹤0.01% 2788
2014
Q4
$15K Sell
202
-1,782
-90% -$125K ﹤0.01% 1795
2014
Q3
$117K Sell
1,984
-7,480
-79% -$473K 0.01% 807
2014
Q2
$632K Buy
9,464
+2,008
+27% +$128K 0.08% 189
2014
Q1
$453K Buy
7,456
+6,080
+442% +$362K 0.06% 224
2013
Q4
$73K Sell
1,376
-5,498
-80% -$289K 0.01% 1072
2013
Q3
$343K Buy
6,874
+6,500
+1,738% +$312K 0.04% 450
2013
Q2
$17K Buy
+374
New +$16.3K ﹤0.01% 1874

Other funds holding IDXX

Tower Research Capital (TRC)'s IDXX Position: Q1 2026 in Review

Tower Research Capital (TRC) increased its Idexx Laboratories (IDXX) stake by 11% in Q1 2026, buying an estimated $276K and bringing the position to 4,535 shares worth $2.55M. The position accounts for 0.07% of the portfolio, ranked #293.

Tower Research Capital (TRC) first reported a position in IDXX in Q2 2013 and has held it in 49 quarters since. The position peaked at $13.4M in Q1 2022. 1,312 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Tower Research Capital (TRC) held 4,535 shares of Idexx Laboratories worth $2.55M as of Q1 2026.
  • Tower Research Capital (TRC) bought 431 Idexx Laboratories shares in Q1 2026, an estimated $276K.
  • Idexx Laboratories made up 0.07% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #293 holding.
  • Tower Research Capital (TRC) first reported a position in Idexx Laboratories in Q2 2013 and has held it in 49 quarters since.
  • Tower Research Capital (TRC)'s Idexx Laboratories position peaked at $13.4M in Q1 2022.
  • 1,312 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.